A Study of LY3461767 in Healthy Participants

NCT04352114 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3461767 - SC
DRUG: LY3461767 - IV
DRUG: Placebo - SC

Sponsor

Eli Lilly and Company